Provided is a method of determining a concentration (C.sub.a) of a first analyte (a) in sweat excreted by a first sweat gland type at a first skin location (i) having the first sweat gland type and a second sweat gland type. The method comprises measuring a first concentration (I) of the first analyte in sweat excreted at the first skin location and measuring at least one parameter of sweat excreted by the second sweat gland type at a second skin location (ii) having the second sweat gland type but not the first sweat gland type. The at least one parameter is used to determine a dilution factor (II) which quantifies dilution of the first analyte by sweat excreted by the second sweat gland type at the first skin location. This dilution factor (II) is then used to correct the first concentration (I) so as to determine the concentration (C.sub.a). Further provided is an apparatus (100) for determining the concentration (C.sub.a).

An elongated device and a system that at the same time allow acquisition of temperature-related data of high spatial and temporal resolution from hollow structures together with other relevant data of physical or chemical variables. In a preferred embodiment infrared or visible light sensors are used to obtain thermal or color images from the inner surface during imposed change of the temperature in the lumen of the hollow structure. The disclosure makes it possible to evaluate thermal variations when the inner surface returns to pre-change thermal conditions. High-resolution data can be obtained with the disclosure. The disclosure further includes a system with rotators, injection pumps, a control unit and display operably coupled to one or more of the data acquisition and processing system.

A scalable configurable universal complete spectrum concise datasets platform is provided that utilizes measure points from sensor-observation-derived representations or concise datasets in the making of selected cyber determinations regarding or utilizing sensor observations or sensor observation subjects. The platform utilizes necessary resources and predetermined criteria in the making of selected cyber determinations, the platform utilizes measure points and personalized processes in the accurate or reliable locating of selected analytically rich aspects, characteristics or features from sensor-observation-derived representations, wherein appropriate informational representations are assigned to selected analytically rich aspects, characteristics, features, measure points or the sensor observation and stored in concise datasets where they may be utilized in real-time or thereafter in the making of selected cyber determinations regarding or utilizing sensor observations or sensor observation subjects. The platform is configurable for being utilized as a touchless user interface, a 100% accurate cyberspace identity test or a universal health metrics monitor.

A sheathed tubular semi-rigid balloon catheter for performing probing, irrigation, dilation, suction and potential intubation of the nasolacrimal system or paranasal sinus system to treat for stenosis or obstruction. The catheter includes a sheathed tubular probe portion through which a tracer fluid can be injected and through which suctioning of blood or other material can be conducted. The sheath portion of the device can have a distal segment that is inflated in order to dilate parts the nasolacrimal or paranasal sinus system. The high axial load accommodating catheter tool includes a more secure and inexpensively manufactured bond between the metallic semi-rigid tube of the probe portion and the plastic hand-manipulable, multi-connector hub using an enlarged bonding collar.

Among the various aspects of the present disclosure is the provision of methods and systems for segmenting images and expediting a contouring process for MRI-guided adaptive radiotherapy (MR-IGART) comprising applying a convolutional neural network (CNN), wherein the CNN accurately segments organs (e.g., the liver, kidneys, stomach, bowel, or duodenum) in 3D MR images.

Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.

Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.

Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.

Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.

Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.